Structure-activity relationship study of selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101) and absolute configurational assignment using infrared and vibrational circu

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2012-05-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm300345zPMID 22594609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cited by this paper
• Structure−Activity Relationship Study of First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101)

  2010cited by this paper
• Near-Infrared and Mid-Infrared Fourier Transform Vibrational Circular Dichroism of Proteins in Aqueous Solution

  2010cited by this paper
• Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1.

  2009cited by this paper
• Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia

  2009cited by this paper
• Excitatory amino acid transporters as potential drug targets

  2009cited by this paper
• Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.

  2009cited by this paper
• Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes*

  2008cited by this paper
• Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.

  2008cited by this paper
• Excitotoxic neuronal death and the pathogenesis of Huntington's disease.

  2008cited by this paper
• Absolute configuration and conformation analysis of 1-phenylethanol by matrix-isolation infrared and vibrational circular dichroism spectroscopy combined with density functional theory calculation.

  2007cited by this paper
• Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

  2007cited by this paper
• An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.

  2007cited by this paper
• Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

  2007cited by this paper
• The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

  2007cited by this paper
• Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.

  2006cited by this paper
• Fourier transform near-infrared vibrational circular dichroism used for on-line monitoring the epimerization of 2,2-dimethyl-1,3-dioxolane-4-methanol: A pseudo racemization reaction.

  2006cited by this paper
• Absolute configuration of natural diastereoisomers of 6beta-hydroxyhyoscyamine by vibrational circular dichroism.

  2006cited by this paper
• Glutamate- and GABA-based CNS therapeutics.

  2006cited by this paper
• Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.

  2006cited by this paper
• Divergent asymmetric synthesis of 3,5-disubstituted piperidines.

  2006cited by this paper
• Absolute configurations of endoperoxides determined by vibrational circular dichroism (VCD)

  2006cited by this paper
• Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.

  2004cited by this paper
• Configurational and conformational analysis of chiral molecules using IR and VCD spectroscopies: spiropentylcarboxylic acid methyl ester and spiropentyl acetate.

  2002cited by this paper
• Addition of Dienolates to Sulfinimines. Stereoselective Synthesis of Dihydropyridones.

  2001cited by this paper
• Asymmetric Synthesis of the Four Stereoisomers of 4-Hydroxypipecolic Acid

  2000cited by this paper
• QUANTUMCHEMICAL CALCULATION OF CD SPECTRA : THE ABSOLUTE CONFIGURATION OF PALMARUMYCINS CP3 AND C2

  1997cited by this paper
• Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected N(alpha)-(omega-Aminoalkyl)amino Acids and N(alpha)-(omega-Carboxyalkyl)amino Acids.

  1997cited by this paper
• Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected Nα-(ω-Aminoalkyl)amino Acids and Nα-(ω-Carboxyalkyl)amino Acids

  1997cited by this paper
• Enantioselective synthesis of (R)-and (S)-α-aminoacids using (6S)- and (6R)-6-methyl-morpholine-2,5-dione derivatives

  1996cited by this paper
• Novel 6-5 fused ring heterocycle antifolates with potent antitumor activity: bridge modifications and heterocyclic benzoyl isosters of 2,4-diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine antifolate.

  1995cited by this paper
• Validity of additivity approximations used in GAUSSIAN‐2 theory

  1992cited by this paper
• Gaussian-2 theory for molecular energies of first- and second-row compounds

  1991cited by this paper
• Gaussian‐1 theory: A general procedure for prediction of molecular energies

  1989cited by this paper
• Effect of electron correlation on theoretical vibrational frequencies

  1982cited by this paper

• Toward pharmaceutical selective laser sintering 3D printing - a thermal and temperature-dependent analysis perspective.

  2025cites this paper
• Copper-Catalyzed Enantioselective Formal [4 + 1] and [3 + 3] Cycloaddition of Ethynylethylene Carbonates.

  2023cites this paper
• Multicomponent Synthesis of Tetrahydrobenzo[b]Pyrans, Pyrano[2,3-d]Pyrimidines, and Dihydropyrano[3,2-c]Chromenes Catalyzed by Sodium Benzoate

  2022cites this paper
• Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges

  2022cites this paper
• New camptothecin derivatives for generalized oncological chemotherapy: synthesis, stereochemistry and biology.

  2021cites this paper
• Ru-Catalyzed Switchable N-Hydroxyethylation and N-Acetonylation using Crude Glycerol.

  2020cites this paper
• Asymmetric Construction of 4 H-Pyrano[3,2- b]indoles via Cinchonine-Catalyzed 1,4-Addition of 2-Ylideneoxindole with Malononitrile.

  2019cites this paper
• Absolute Configurations of Synthetic Molecular Scaffolds from Vibrational CD Spectroscopy.

  2019cites this paper
• Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin

  2017cites this paper
• Bioavailability Studies and in vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH‐102

  2016cites this paper
• New Insight into the Structure–Activity Relationships of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors UCPH‐101 and UCPH‐102

  2016cites this paper
• Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure-Activity Relationship Study.

  2016cites this paper
• A practical green chemistry approach to synthesize fused bicyclic 4H-pyranes via an amine catalysed 1,4-addition and cyclization cascade

  2016cites this paper
• Chemoselective synthesis, spectral and computational studies of 2-amino-3-cyano-4-aryl-4H-chromen-7-yl alkyl carbonates

  2016cites this paper
• Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes.

  2016cites this paper
• SLC transporters as therapeutic targets: emerging opportunities

  2015cites this paper
• Thrombin decreases expression of the glutamate transporter GLAST and inhibits glutamate uptake in primary cortical astrocytes via the Rho kinase pathway.

  2015cites this paper
• β-Amino Esters from the Reductive Ring Opening of Aziridine-2-carboxylates

  2014cites this paper
• Probing for Improved Potency and In Vivo Bioavailability of Excitatory Amino Acid Transporter Subtype 1 Inhibitors UCPH-101 and UCPH-102: Design, Synthesis and Pharmacological Evaluation of Substituted 7-Biphenyl Analogs

  2014cites this paper
• Structural and functional dynamics of Excitatory Amino Acid Transporters (EAAT)

  2014cites this paper
• Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain

  2013cites this paper
• Vibrational circular dichroism discrimination of diastereomeric cedranol acetates.

  2013cites this paper
• The SLC1 high-affinity glutamate and neutral amino acid transporter family.

  2013cites this paper
• SLC1 glutamate transporters

  2013cites this paper
• Mechanisms of glutamate transport.

  2013cites this paper
• Structure-activity-relationship study of N-acyl-N-phenylpiperazines as potential inhibitors of the Excitatory Amino Acid Transporters (EAATs): improving the potency of a micromolar screening Hit is not truism

  2013cites this paper
• Modulateurs du transport vésiculaire du glutamate : développement d’outils pharmacologiques et de diagnostic pour la maladie d’Alzheimer

  2012cites this paper